Effects of virtual reality on balance in people with diabetes: a systematic review and meta-analysis.

J Diabetes Metab Disord

Department of Health & Rehabilitation Sciences, College of Allied Health Professions, University of Nebraska Medical Center, 68198 Omaha, NE USA.

Published: June 2024

Purpose: This systematic review aims to identify, critically appraise, and synthesize the effects of virtual reality on balance in people with diabetes.

Methods: Five biomedical databases were searched from inception to December 15, 2023. Clinical trials investigating the effects of virtual reality on performance-based or patient-reported outcome measures related to balance function among people with diabetes were included. Two independent reviewers conducted study selection, data extraction, and quality assessment. Cochrane risk-of-bias tool-2 were used to assess included studies. Meta-analysis was performed to examine the effects of the intervention.

Results: Six studies with a total of 257 participants were identified. Two studies had high risk of bias, and four studies had some concerns regarding risk of bias. No adverse events related to virtual reality were reported. Meta-analysis revealed significant improvements in the Berg Balance Scale (SMD = 1.56, 95% CI 0.71 to 2.40,  < 0.001), Timed Up and Go test (SMD = -0.74, 95% CI -1.21 to -0.28,  = 0.002), and falls efficacy (SMD = 0.99, 95% CI 0.43 to 1.54,  < 0.001) following virtual reality intervention. No significant differences were found for postural sway and single leg stance measures.

Conclusion: Virtual reality-based rehabilitation demonstrates promising effects for improving balance in people with diabetes. Further studies with high methodological quality and large sample sizes are warranted.

Supplementary Information: The online version contains supplementary material available at 10.1007/s40200-024-01413-7.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11196464PMC
http://dx.doi.org/10.1007/s40200-024-01413-7DOI Listing

Publication Analysis

Top Keywords

virtual reality
16
effects virtual
12
reality balance
8
balance people
8
people diabetes
8
systematic review
8
risk bias
8
effects
4
reality
4
balance
4

Similar Publications

Background: This scoping review aimed to explore the existing literature on teaching clinical reasoning in the field of forensic medicine.

Methods: The scoping review was conducted following the PRISMA extension for scoping reviews.

Results: The initial search yielded a total of 98 articles, of which 40 studies met the inclusion criteria.

View Article and Find Full Text PDF

Comprehensive VR dataset for machine learning: Head- and eye-centred video and positional data.

Data Brief

December 2024

Department of Neurophysics, Philipps University Marburg, Karl-von-Frisch Straße 8a, 35043 Marburg, Hesse, Germany.

We present a comprehensive dataset comprising head- and eye-centred video recordings from human participants performing a search task in a variety of Virtual Reality (VR) environments. Using a VR motion platform, participants navigated these environments freely while their eye movements and positional data were captured and stored in CSV format. The dataset spans six distinct environments, including one specifically for calibrating the motion platform, and provides a cumulative playtime of over 10 h for both head- and eye-centred perspectives.

View Article and Find Full Text PDF

Objective: Family caregivers (FCGs) of cancer patients who are in hospice experience psychological challenges and poor quality of life (QOL) as a consequence of caregiving demands and anticipatory loss. Supportive interventions are needed. Exposure to nature offers a source of relaxation; however, FCGs are often homebound and have limited opportunities for respite.

View Article and Find Full Text PDF

Efficacy and safety of iclepertin (BI 425809) with adjunctive computerized cognitive training in patients with schizophrenia.

Schizophr Res Cogn

June 2025

Boehringer Ingelheim Pharmaceuticals, Inc., 900 Ridgebury Road, Ridgefield, CT 06877, USA.

Unlabelled: Despite significant patient burden, there are no approved pharmacotherapies to treat symptoms of cognitive impairment associated with schizophrenia (CIAS). This double-blind, placebo-controlled, parallel-group Phase II trial assessed the efficacy and safety of pharmacological augmentation of at-home computerized cognitive training (CCT) with iclepertin (BI 425809, a glycine transporter-1 inhibitor). Participants with schizophrenia (aged 18-50 years) on stable antipsychotic therapy, who were compliant with CCT during the run-in period, were enrolled.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!